Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Catherine Moste"'
Autor:
Houda Boukhebza, Amélie De Saint Jean, Régis Sodoyer, Julie Medina, Isabelle Legastelois, Catherine Moste
Publikováno v:
Vaccine. 33:4221-4227
The yield of influenza antigen production may significantly vary between vaccine strains; for example the A/California/07/09 (H1N1)-X179A vaccine virus, prepared during 2009 influenza pandemic, presented a low antigen yield in eggs compared to other
Autor:
Nolwenn Nougarede, Marie-Pierre Varenne, Catherine Moste, Isabelle Legastelois, Julien Prudent, Sophie Buffin, Joseline Dubayle, Nabila Ikhelef
Publikováno v:
Journal of virological methods. 251
To formulate inactivated influenza vaccines, the concentration of hemagglutinin (HA) must be accurately determined. The standard test currently used to measure HA in influenza vaccines is the Single Radial Immunodiffusion (SRID) assay. We developed a
Autor:
Corinne Pion, Marie-Clotilde Bernard, Catherine Moste, Emanuelle Trannoy, Isabelle Legastelois, Marie-Claire Nicolaï, Virginie Courtois, Stéphanie Husson, Philippe Talaga, Régis Sodoyer
Publikováno v:
Vaccine. 32:5570-5576
a b s t r a c t The membrane displayed antigen haemagglutinin (HA) from several influenza strains were expressed in the Leishmania tarentolae system. This non-conventional expression system based on a parasite of lizards, can be readily propagated to
Autor:
Emmanuelle Totain, Julie Medina, Catherine Moste, Vincent Guillot, Isabelle Legastelois, Régis Sodoyer, Marie Rouleau
Publikováno v:
Journal of Virological Methods. 196:25-31
Seasonal and pandemic influenza vaccine manufacturing is challenged with a tight production schedule. Reverse genetics constitutes a rapid method for creating viruses. Vero and CHOK1 cells were found to be an appropriate cell mixture for the generati
Autor:
Catherine Moste, Alexandra Pilloud, Nicolas Devard, Régis Sodoyer, Marie-Clotilde Bernard, Christelle Serraille, Michel Chevalier, Olivier Engel, Martine Fouque, Isabelle Legastelois, Aymeric de Montfort
Publikováno v:
Journal of Virological Methods. 178:129-136
Two IgM monoclonal antibodies (MAbs), Y6F5 and Y13F9, were selected during a screening of clones obtained immunising BALB/c mice with purified envelop proteins of the A/Sydney/5/97 (H3N2) IVR108 influenza strain. These MAbs recognised avian glycans o
Autor:
Yves Girerd-Chambaz, Veronique Barban, Sandrine Gulia, M. Aguirre, Nathalie Mantel, S. Colombani, Catherine Moste
Publikováno v:
Journal of Virological Methods. 151:40-46
Yellow fever-dengue chimeras (CYDs) are being developed currently as live tetravalent dengue vaccine candidates. Specific quantitative assays are needed to evaluate the viral load of each serotype in vaccine batches and biological samples. A quantita
Autor:
Tafani Jp, Jim Tartaglia, Therese-Marie Jourdier, Delisle F, Catherine Moste, Moingeon P, Devauchelle P, Marie-Claude Bonnet
Publikováno v:
Gene Therapy. 10:2126-2132
We tested the canarypox virus vector ALVAC and the genetically attenuated vaccinia virus vector NYVAC as vehicles for achieving local immunomodulation in domestic animals bearing spontaneous tumours. Following intratumoral administration of ALVAC-, o
Autor:
Claude Leclerc, Marie Paule Kieny, Jean-Louis Excler, Eliane Coëffier, Bernard Meignier, Dominique Salmon-Ceron, James Tartaglia, Catherine Moste, Gilles Pialoux
Publikováno v:
AIDS Research and Human Retroviruses. 13:1471-1485
We analyzed the fine specificity of anti-V3 antibodies elicited in three different species (human, guinea pig, and macaque) by various HIV candidate vaccines. Following immunization with recombinant canarypox virus expressing gp160MN or with recombin
Autor:
Inca C. Kusters, Aymeric de Montfort, Fabienne Piras, Frederick R. Vogel, Marie-Clotilde Bernard, Florence Boudet, Catherine Caillet, Catherine Moste, Agnes Hoffenbach
Publikováno v:
Vaccine. 28(18)
Pandemic influenza vaccines have been manufactured using the A/California/07/2009 (H1N1) strain as recommended by the World Health Organization. We evaluated in mice the immunogenicity of pandemic (H1N1) 2009 vaccine and the impact of prior vaccinati
Autor:
Adolfo García-Sastre, Isabelle Legastelois, Catherine Moste, Peter Palese, Terrence M. Tumpey, Jacqueline M. Katz, Frederick R. Vogel, Taronna R. Maines
Publikováno v:
Influenza and Other Respiratory Viruses
Background In case of influenza pandemic, a robust, easy and clean technique to prepare reassortants would be necessary. Objectives Using reverse genetics, we prepared two vaccine reassortants (A/H5N1 × PR8 and A/H7N1 × PR8) exhibiting the envelope